Clinical Trial Update: Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain [Phase 2]

View source ↗

Summary

Phase 2 trial results update for XT-150 in facet joint osteoarthritis pain, reporting safety and efficacy data; the study is completed and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Facet Joint Osteoarthritis

Drugs mentioned

• XT-150

Snippet

Sponsor: Xalud Therapeutics, Inc. | Conditions: Facet Joint Pain, Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2025-01-15